Related Experiment Video
Updated: Aug 6, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
The PREVENT Risk Equations and Cardiovascular Prevention in East Asia
Mitsuaki Sawano1,2,3, Kentaro Ejiri4, Yuichiro Mori5
1Teikyo Academic Research Center, Teikyo University.
The PREVENT equations show promise for cardiovascular risk prediction in East Asia, though further validation is needed, especially for heart failure. Early studies suggest good transportability across diverse East Asian populations.
Area of Science:
- Cardiology
- Epidemiology
- Preventive Medicine
Background:
- Cardiovascular disease (CVD) is a major health concern in East Asia, with unique epidemiological trends.
- Aging populations in East Asia are increasing chronic kidney disease, diabetes, and heart failure, heightening the need for accurate CVD risk prediction.
- Existing Western-derived risk models often overestimate CVD risk in East Asian populations.
Purpose of the Study:
- To review the evolution of cardiovascular risk prediction models.
- To highlight the innovations of the PREVENT equations within an integrated cardiovascular-kidney-metabolic framework.
- To assess the performance and transportability of the PREVENT equations in East Asian populations.
Main Methods:
- Review of existing literature on cardiovascular risk prediction models.
- Analysis of the PREVENT equations' framework and components.
- Examination of emerging validation studies of PREVENT in East Asian cohorts (Korea, China, Japan).
Main Results:
- Traditional models like Framingham, Pooled Cohort Equations, and SCORE require recalibration for East Asian populations.
- Early validation studies from Korea and China suggest the PREVENT equations are reasonably transportable.
- Evidence from Japan is limited, indicating a need for further validation and potential recalibration.
Conclusions:
- The PREVENT equations represent a significant advancement in cardiovascular risk prediction, integrating kidney and metabolic factors.
- While initial findings in East Asia are encouraging, further research is essential for widespread clinical implementation.
- Challenges remain in heart failure prediction, incorporating additional variables, leveraging electronic health records, and exploring AI-assisted risk assessment.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Relative Risk
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Preventive Healthcare Services